[{"address1": "4870 Sadler Road", "address2": "Suite 300", "city": "Glen Allen", "state": "VA", "zip": "23060", "country": "United States", "phone": "(804) 487-8196", "website": "https://www.adial.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 63, "title": "CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 561331, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 328500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vinay  Shah A.C.A., M.B.A.", "age": 61, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Andrew  Taubman", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brigette  Robertson M.D.", "age": 60, "title": "Acting Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Abel  Svitavsky CPA", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.78, "open": 0.9, "dayLow": 0.6308, "dayHigh": 1.21, "regularMarketPreviousClose": 0.78, "regularMarketOpen": 0.9, "regularMarketDayLow": 0.6308, "regularMarketDayHigh": 1.21, "payoutRatio": 0.0, "beta": 1.258, "forwardPE": -0.5037594, "volume": 23574258, "regularMarketVolume": 23574258, "averageVolume": 1269082, "averageVolume10days": 3095300, "averageDailyVolume10Day": 3095300, "bid": 0.4599, "ask": 0.8223, "bidSize": 2, "askSize": 2, "marketCap": 4404975, "fiftyTwoWeekLow": 0.58, "fiftyTwoWeekHigh": 3.0, "fiftyDayAverage": 0.718, "twoHundredDayAverage": 0.935, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 654448, "profitMargins": 0.0, "floatShares": 6146385, "sharesOutstanding": 6574590, "sharesShort": 217057, "sharesShortPriorMonth": 549373, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.033, "heldPercentInsiders": 0.01397, "heldPercentInstitutions": 0.093660004, "shortRatio": 3.34, "shortPercentOfFloat": 0.0335, "impliedSharesOutstanding": 6574590, "bookValue": 0.628, "priceToBook": 1.0668789, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -13197451, "trailingEps": -2.72, "forwardEps": -1.33, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": -0.079, "52WeekChange": -0.5889571, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 0.67, "targetHighPrice": 7.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 3750525, "totalCashPerShare": 0.57, "ebitda": -8283892, "totalDebt": 0, "quickRatio": 3.843, "currentRatio": 4.159, "returnOnAssets": -1.05879, "returnOnEquity": -3.238, "freeCashflow": -3994250, "operatingCashflow": -6922306, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ADIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1746230253, "regularMarketTime": 1746216001, "shortName": "Adial Pharmaceuticals, Inc", "longName": "Adial Pharmaceuticals, Inc.", "exchange": "NCM", "messageBoardId": "finmb_112638788", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -14.102559, "regularMarketPrice": 0.67, "marketState": "CLOSED", "corporateActions": [], "cryptoTradeable": false, "postMarketChangePercent": 2.73134, "postMarketPrice": 0.6883, "postMarketChange": 0.0183, "regularMarketChange": -0.109999955, "regularMarketDayRange": "0.6308 - 1.21", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1269082, "fiftyTwoWeekLowChange": 0.09000003, "fiftyTwoWeekLowChangePercent": 0.15517248, "fiftyTwoWeekRange": "0.58 - 3.0", "fiftyTwoWeekHighChange": -2.33, "fiftyTwoWeekHighChangePercent": -0.77666664, "fiftyTwoWeekChangePercent": -58.895706, "earningsTimestamp": 1741095000, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532698200000, "epsTrailingTwelveMonths": -2.72, "epsForward": -1.33, "epsCurrentYear": -1.74667, "priceEpsCurrentYear": -0.38358706, "fiftyDayAverageChange": -0.047999978, "fiftyDayAverageChangePercent": -0.06685234, "twoHundredDayAverageChange": -0.265, "twoHundredDayAverageChangePercent": -0.28342244, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Adial Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]